No study has ever tested ashwagandha and alcohol together. There is no trial, no pharmacokinetic work on the pair and no measured interval, so the specific waiting times printed across the first page of search results have nothing behind them.
What does exist is an inference. Drugs.com grades the pair 'moderate' by joining two separate facts - ashwagandha has been named in rare liver injury reports, and alcohol acts on the liver. That is reasoning rather than measurement, and an absence of evidence is not evidence that the combination is harmless.
Type 'ashwagandha and alcohol' into a search box and the first page will answer you: leave four hours between them; leave a day; one drink but not three. The answers are specific, delivered without hesitation, and several of them contradict each other. None of them mentions that the combination has never been studied.
That is the actual finding here, and it is more use than any number of hours. There is no trial in which one group took ashwagandha with alcohol and another did not, and no study of what a drink does to the absorption of withanolides or of what ashwagandha does to the rate at which alcohol clears. A question asked constantly has never been the subject of an experiment, and everything printed as an answer is something else wearing an answer's clothes.
What does a drug interaction actually mean?
In pharmacology an interaction is not a general unease about two things meeting in the same stomach. It is a claim that one substance changes what another does, and it comes in two kinds. A pharmacokinetic interaction changes how much of something reaches the blood, or how long it stays there: one substance occupies the liver enzyme that clears the other, or slows the gut, or competes for the same transporter. A pharmacodynamic interaction leaves the concentrations where they were and acts on the same target from two directions - two sedatives on one receptor is the standard example.
How an interaction is tested, and what the result looks like
Establishing either kind is ordinary work with a fixed shape. For the pharmacokinetic sort you give volunteers substance A alone, then A with B, and take blood at intervals. The result is a ratio - the area under the concentration curve with B divided by the area without it - and that ratio is the interaction: a number rather than an adjective. Below that sit laboratory studies on human liver enzymes in a dish, which show what is chemically plausible, not what happens at the amounts people swallow. Below those sit case reports: one person, one outcome, no comparison group, and usually several other things at once.
For ashwagandha and alcohol the top two levels are empty. What exists sits at the third, which was never designed to answer this kind of question.
What do the interaction databases say about ashwagandha and alcohol?
Drugs.com, where most of the confident pages eventually point, does carry an entry. Its checker grades ashwagandha with ethanol as a 'moderate' interaction. The consumer text opens: 'Talk to your doctor before using ethanol (alcohol) together with ashwagandha.' The reason given is that products containing ashwagandha have been reported to cause liver injury in rare cases, and that alcohol is another thing which acts on the liver, so taking both may add to that risk.
Two facts and a join: what the database entry is made of
Read the shape of that sentence. It is two facts and a join. Fact one: ashwagandha has been named in liver injury reports. Fact two: alcohol affects the liver. The join - therefore the two together carry more risk than either alone - is reasoning, not measurement. It may well be right, and it is the default a cautious pharmacologist applies. Databases are built to apply it, because one that stayed silent whenever nobody had run the study would be silent about almost everything. But it is an entry generated by a rule, and in the public mind it does the work of an entry generated by an experiment.
The first of the two facts is solid. The NIH LiverTox database, the reference for liver injury from medicines and supplements, updated its ashwagandha monograph in December 2024. The plant it covers is Withania somnifera, a nightshade rather than a ginseng despite the 'Indian ginseng' listed among its other names. The monograph carries a likelihood score of B - a likely cause of clinically apparent liver injury - and describes injury appearing two to twelve weeks after starting, with jaundice and itching, generally resolving within one to four months of stopping. It records rare instances of fatal injury or emergency transplantation in people who already had cirrhosis or advanced liver disease, and states that use should be avoided in that group.
What that monograph does not have is a section on alcohol. The word appears five times in the entire document. Once it is a solvent, in a 1986 rat study that used alcohol extracts of the leaves. The other four sit inside two case reports where a person happened to be drinking. In the first, a woman had been taking 2,100 mg of ashwagandha a day for a year, alongside 1,200 mg of ibuprofen a day and what the authors call modest alcohol intake. In the second, a man with severe alcohol use disorder took an eight-ingredient herbal product - ashwagandha was one of the eight - for withdrawal symptoms, and developed jaundice three days later.
Those two reports are the nearest thing in the literature to evidence about the pair, and neither is evidence about the pair. One has a year of high-dose ibuprofen in the middle of it; the other, an eight-plant blend and a liver with a long history. A case report can flag a question. It cannot settle one, because there is nothing to compare it against.
The other two reference works are quieter still. The NCCIH page names the medicine classes it says ashwagandha might interact with - those for diabetes and high blood pressure, immunosuppressants, sedatives, anticonvulsants and thyroid hormone - and alcohol is not among them. It also lists drowsiness among reported side effects, where the second popular line of reasoning starts. The same page is where the plainest safety sentence sits, and it is about the plant on its own, before anybody adds a drink to it: "There is not enough information to allow conclusions about its long-term safety to be reached."
None of this makes the combination safe, and the direction of the gap matters. Nothing has been looked for, so nothing has been found. That is a different statement from having looked and found nothing, and the second statement is not available to anybody.
Why does every website give a different waiting time?
Follow the chain back and it is short and repetitive. At one end sits a hedged professional line: a database flag, a 'may', a 'talk to your doctor'. Two steps along, a supplement blog rewrites the hedge as a caution. Two steps after that the hedge has gone altogether - 'don't mix ashwagandha and alcohol', no attribution, because the page it was copied from had none either. Somewhere along the way a number gets added, and the number is the tell.
Where the specific number of hours comes from
The invented part is usually the number. Four hours, six hours, wait until the next day: these turn up in article after article with nothing cited, and nothing they could cite, because measuring an interval means measuring an interaction first and nobody has. A figure like that has the texture of pharmacology while being a guess, and it is the part readers repeat, which is how it becomes established without ever having been established.
Underneath the copying is a funding question with a dull answer. When a medicine is licensed, the authorisation holder has to characterise its interactions and print them in the product information, and can afford to because it has exclusive rights to sell what it studied. Ashwagandha is a plant, regulated as food rather than licensed as a medicine, nobody owns it, no authority can compel anyone to study it, and a company that paid for a crossover trial would hand the result to its competitors the following week. So the trial does not happen - not because an answer is being kept from you, but because nothing exists that would commission it.
The size of the amounts is worth holding in view throughout. LiverTox describes ashwagandha root extract sold in capsules of 150 to 600 mg, taken one to three times a day; the case reports it cites run as high as 2,100 mg daily. Our tablet contains 10 mg of ashwagandha, one of six plants in a 100 mg blend, at a maximum of one tablet in any 24 hours. That is not an argument that our tablet is fine with a drink, and it is not offered as one. It is a note that the published material was written about a different order of magnitude, and nothing at all has been published about this one.
Why does a UK supplement label say nothing about alcohol?
Turn over any food supplement sold in the UK and you will find a fixed set of items: the ingredients with the amount of each per daily portion, the portion itself, a warning not to exceed it, a line about supplements not replacing a varied and balanced diet, and one about keeping the product away from young children. There is no interactions field, because interactions belong to the medicines system: a licensed medicine has a patient information leaflet with a section for them, approved by the regulator. A food supplement has neither, so it has nowhere to put such a statement and no standing to make one.
A pack that printed a specific instruction about alcohol would therefore not be more forthcoming than the rest of us. It would be asserting something it has no basis to assert. What our pack carries instead is the ceiling - a maximum of one tablet in any 24 hours - and two exclusions: not for under-18s, and not for anyone taking prescription medicines without speaking to their GP first. That second line covers far more ground than an alcohol sentence would, because prescription medicines are where the documented ashwagandha interactions sit.
Who to ask instead: a pharmacist or your GP
The useful move is to change who you are asking. A search engine has no idea what else you take. A pharmacist can look at your record, does not charge, and in Britain will talk to you over the counter without an appointment. If you take prescription medicines, or have a liver condition, that is a GP question rather than a website question. Either way the person answering has the two things a search result does not: your history, and the ability to be wrong about you specifically and then corrected.
Take the pack with you. Ours prints all six plants with their milligrams and Latin names, and the batch code and best-before date are on the blister foil. Quote that code to hello@maleup.co.uk and we will send the certificate of analysis for your batch.
None of this produces the number the search results promise. An honest answer to a question nobody has studied is a description of the gap, plus the name of the person who can answer it for you. The pages offering four hours instead are not better informed. They are only better at sounding as though they are.
- A pharmacological interaction is a measurable claim: volunteers take one substance, then both, and the blood levels are compared.
- No such study exists for ashwagandha and alcohol, and no laboratory enzyme work on the pair exists either.
- The Drugs.com 'moderate' grading is a rule-generated inference from two separate facts, not an observation of the two taken together.
- The NIH LiverTox monograph has no alcohol section, and NCCIH's list of interacting medicine classes does not include alcohol.
- Doses in the literature run from 150 to 600 mg of extract, and up to 2,100 mg daily in case reports. Our tablet holds 10 mg of ashwagandha, at most one tablet in any 24 hours.
Common questions
Has anyone studied ashwagandha and alcohol together?
No. There is no published trial in which one group took ashwagandha with alcohol and another did not, no pharmacokinetic study of what alcohol does to the absorption of withanolides, and no laboratory work on the pair. The confident answers on the first page of search results are not reporting a study, because there is no study to report.
Why does Drugs.com list ashwagandha and alcohol as a moderate interaction?
Because of an inference rather than an observation. The entry joins two separate facts: products containing ashwagandha have been reported to cause liver injury in rare cases, and alcohol is another substance that acts on the liver. Its consumer text opens 'Talk to your doctor before using ethanol (alcohol) together with ashwagandha.' Interaction databases are built to make that kind of default join, because one that stayed silent whenever nobody had run a study would be silent about almost everything.
How long should you leave between ashwagandha and a drink?
No published figure exists. Measuring an interval requires measuring an interaction first, and nobody has measured one for this pair. The four-hour and six-hour figures repeated online carry no citation, and there is nothing they could cite. Anyone who needs an answer for their own circumstances is asking a pharmacist or GP, not a search engine.
Does ashwagandha affect the liver?
The NIH LiverTox database, updated in December 2024, gives ashwagandha a likelihood score of B, meaning a likely cause of clinically apparent liver injury. It describes injury appearing two to twelve weeks after starting, usually resolving within one to four months of stopping, with rare instances of fatal injury or emergency transplantation in people who already had cirrhosis or advanced liver disease. LiverTox states that use should be avoided in that group. The monograph contains no section on alcohol.
Does the AllMaleUp label say anything about alcohol?
No, and no UK food supplement label does. A food supplement label carries the ingredients and their amounts, the portion, a warning not to exceed it, and the standard statements about a varied diet and keeping the product away from children. Interactions belong to the medicines system, where a licensed product has a patient information leaflet with a section for them. Our pack instead states a maximum of one tablet in any 24 hours, and that it is not for under-18s or for anyone taking prescription medicines without speaking to their GP first.
How much ashwagandha is in an AllMaleUp tablet?
Ten milligrams, one of six botanicals in a 100 mg blend, with a maximum of one tablet in any 24-hour period. For context, LiverTox describes ashwagandha extract sold in capsules of 150 to 600 mg taken one to three times a day, and the case reports it cites run as high as 2,100 mg daily. That is a note about the scale of the published material, not a statement about the safety of our product with alcohol, on which nothing has been published either.
- Ashwagandha - drug record — LiverTox, NIDDK / NCBI Bookshelf Updated 3 December 2024. Likelihood score B; no alcohol section.
- Ashwaganda + Ethanol interaction report — Drugs.com interaction checker Graded 'moderate'; the reasoning given is liver-based.
- Ashwagandha: Usefulness and Safety — National Center for Complementary and Integrative Health, NIH Lists interacting medicine classes; alcohol is not among them.
- Know the Science: How Medications and Supplements Can Interact — National Center for Complementary and Integrative Health, NIH
- A case of supplement-induced hepatitis — Cureus 2022;14:e30433 2,100 mg daily for a year, with ibuprofen and modest alcohol intake.
- Supplements are not a synonym for safe: suspected liver injury from ashwagandha — Federal Practitioner 2023;40:315-319 Eight-ingredient product taken during alcohol withdrawal.
Six botanicals, 100 mg per tablet, every weight printed on the carton: Ginseng 25 mg, Maca 25 mg, Tribulus 20 mg, Guarana 10 mg, Ashwagandha 10 mg, Catuaba 10 mg. Maximum one tablet in any 24-hour period. Pressed in the UK on a GMP-registered line.
See the packs →† Describes the traditional use of these botanicals (UK 'on-hold' botanical claims under retained Regulation (EC) 1924/2006). Not authorised EFSA health claims. AllMaleUp is a food supplement, not a medicine.
